Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27.

Masui, Y; Sugaya, M; Kagami, S; Fujita, H; Yano, S; Nagao, M; Komine, M; Saeki, H; Ihn, H; Kikuchi, K; Tamaki, K

Masui, Y; Sugaya, M; Kagami, S; Fujita, H; Yano, S; Nagao, M; Komine, M; Saeki, H; Ihn, H; Kikuchi, K; Tamaki, K.

Afiliación

Masui Y; Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Clin Exp Dermatol ; 32(1): 57-9, 2007 Jan.

Article en En | MEDLINE | ID: mdl-17305906

ABSTRACT

ABSTRACT

We describe a patient with Sézary syndrome (SS) who was successfully treated with topical steroid and narrowband UVB. Sézary cells in peripheral blood correlated with severity of skin lesions. In addition, serum levels of CCL17 and CCL27 decreased as disease activity improved. These chemokines may be important for the pathogenesis of SS.

Asunto(s)

Quimiocinas CC/sangre; Síndrome de Sézary/terapia; Terapia Ultravioleta; Adulto; Quimiocina CCL17; Quimiocina CCL27; Ensayo de Inmunoadsorción Enzimática; Femenino; Humanos; Síndrome de Sézary/sangre; Resultado del Tratamiento; Terapia Ultravioleta/métodos

Buscar en Google

Imprimir

XML

PubMed Links

Base de datos: MEDLINE Asunto principal: Terapia Ultravioleta / Síndrome de Sézary / Quimiocinas CC Límite: Adult / Female / Humans Idioma: En Revista: Clin Exp Dermatol Año: 2007 Tipo del documento: Article País de afiliación: Japón

Buscar en Google

Imprimir

XML

PubMed Links